Accelerate your path to successful clinical trials

Gain invaluable insights to optimize drug development with an adaptable digital platform that provides high-quality data about trials’ participants from Phase I to Phase III

Clinical trials encounter several challenges

The escalating costs of drug development emphasize the importance of timely decisions

Dropouts and slow patient recruitment are affecting data quality and trial timelines

Traditional assessments lack the sensitivity needed to understand complex conditions

Clinical trials need a technology-based approach that use R&D data to inform rapid decision making

We support your trial participants by closely evaluating any progress in their condition and disease symptoms compared to baseline measurements. By integrating a digital platform into your clinical pipeline, digital objective assessments and ePROMs will be delivered remotely to measure safety, efficacy, and drug’s effectiveness compared to standard treatments or a placebo.

Our cross-disease, multi-symptom platform technology, Colbolt©, requires no additional hardware and provides the broadest reach on the market across iOS and Android devices to capture high-quality data.

Integrate Colbolt© into your trials to gain the insights needed to advance your asset to market

01 Discover how Colbolt© can support your drug trial

Simply translate your needs into a configurable digital platform that can be embedded from pre-clinical to commercialization

02 Deploy Colbolt© before recruiting patients

Configure and deploy Colbolt© to evaluate real world patient data that will shape current drug development activities

03 Recruit patients rapidly and collect continuous data

Recruit a robust pool of patients for the current trial, regardless of location, using smartphone sensors to capture high-quality objective data

04 Evaluate the datasets and publish meaningful results

Rapidly uncover insights through Colbolt© to obtain meaningful results and make decisions regarding your assets

05 Watch Colbolt© scale as your drug trial progresses to the next phase

Drug development doesn’t need to be so complex and expensive. Configure and deploy the Colbolt© platform to meet your goals across each trial phase, setting up for success before your asset reaches the market

Up to 40% reduction in costs related to managing logistics

70% patients retention over 12 months for
high-quality data

5-fold increase in data precision to support your clinical trial

Cross-Disease Applicability with a
Multi Symptom Focus

The Beats Medical Colbolt© platform can be deployed for a variety of CNS and rare conditions, targeting the most common symptoms with digital assessments that measure highly-engaged patients through their smartphones

Mobility

Speech

Dexterity

QoL / ePROMs / Wellbeing

Trusted by

Integrate Colbolt© in your clinical trial

v

102%

increase in physical activity

Facilitates impactful behavioural changes

v

5x

increase in data precison

Generates more precise data than traditional assessments

v

97.9%

accuracy

Greater sensitivity than any other solution in detecting mobility impairements

v

70%

retention rate

Promotes high patient engagement and adherence over long periods